βk-2C-B

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Aethyta (talk | contribs) at 14:58, 31 October 2019. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Βk-2C-B
Clinical data
Routes of
administration
Oral
Legal status
Legal status
Identifiers
  • 2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H12BrNO3
Molar mass274.111 g/mol (freebase)
310.572 g/mol (HCl salt) g·mol−1
3D model (JSmol)
  • COC1=CC(C(=O)CN)=C(OC)C=C1Br
  • InChI=InChI=1S/C10H12BrNO3/c1-14-9-4-7(11)10(15-2)3-6(9)8(13)5-12/h3-4H,5,12H2,1-2H3
  • Key:HFYJGAIOBIDRPX-UHFFFAOYSA-N

βk-2C-B (beta-keto 2C-B, bk-2C-B) is a psychedelic drug which is structurally related to 2C-B and BOB[1] and has been sold online as a designer drug.[2] It was found to be a polymorph and is prone to selfcondensation forming a dimer under basic to neutral conditions, similar to the reaction involved in pyrazine synthesis.[3]

Analogues and derivatives

Legal status

Canada

As of 12 October 2016, βk-2C-B became a controlled substance (Schedule III) in Canada.[8]

Europe

βk-2C-B is illegal in Switzerland,[9] Sweden[10] and the United Kingdom[11]

See also

References

  1. ^ Richard A. Glennon; Mikhail L. Bondarev; Nantaka Khorana; Richard Young; Jesse A. May; Mark R. Hellberg; Marsha A. McLaughlin; Najam A. Sharif (November 2004). "β-Oxygenated Analogues of the 5-HT2A Serotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane". Journal of Medicinal Chemistry. 47 (24): 6034–6041. doi:10.1021/jm040082s. PMID 15537358.
  2. ^ Giampietro Frison; Sara Odoardi; Samuela Frasson; Rocco Sciarrone; Giorgio Ortar; Francesco Saverio Romolo; Sabina Strano Rossi (July 2015). "Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance". Rapid Communications in Mass Spectrometry. 29 (13): 1196–1204. doi:10.1002/rcm.7211. PMID 26395784.
  3. ^ John D. Power; Pierce Kavanagh; John O'Brien; Michael Barry; Brendan Twamley; Brian Talbot; Geraldine Dowling; Simon D. Brandt (June 2015). "Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B)". Drug Testing and Analysis. 7 (6): 512–518. doi:10.1002/dta.1699. PMID 25078895.
  4. ^ "Explore N-(2C-B)-Fentanyl | PiHKAL · info". isomerdesign.com.
  5. ^ "Explore N-(2C-FLY)-Fentanyl | PiHKAL · info". isomerdesign.com.
  6. ^ Glennon, Richard A.; Bondarev, Mikhail L.; Khorana, Nantaka; Young, Richard; May, Jesse A.; Hellberg, Mark R.; McLaughlin, Marsha A.; Sharif, Najam A. (November 2004). "β-Oxygenated Analogues of the 5-HT2ASerotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane". Journal of Medicinal Chemistry. 47 (24): 6034–6041. doi:10.1021/jm040082s. ISSN 0022-2623. PMID 15537358.
  7. ^ Beta-hydroxyphenylalkylamines and their use for treating glaucoma
  8. ^ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Controlled Substances Act. 2016-05-04.
  9. ^ "Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien" (in German). Der Bundesrat.
  10. ^ "Nya substanser klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 18 August 2015.
  11. ^ "Psychoactive Substances Act 2016". Home Office. Retrieved 8 September 2016.